![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Clears nContact’s Cardiac Ablation Device
FDA Clears nContact’s Cardiac Ablation Device
January 23, 2013
nContact announced that the FDA has cleared the company’s modifications to its VisiTrax cardiac ablation device, EPi-Sense, now with embedded sensing capability.
BusinessWire
BusinessWire
Upcoming Events
-
21Oct